Trials / Terminated
TerminatedNCT01008436
Blood Sparing Strategies: Omni-stat Routinary Use in Cardiac Surgery. A Prospective Randomized Study.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (actual)
- Sponsor
- Cardiochirurgia E.H. · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study enrolles all consecutive patients undergoing cardiac surgery at the European Hospital, Rome. The population undergoes randomization to receive usual surgical hemostasis or added topical application of Omni-stat Celox. The two populations are followed up prospectively as regarding blood loss and need for blood transfusions, as well as adverse events at 30 days after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omni-stat Celox | Topical administration of 6 gr of Omnistat Celox |
| DRUG | Control | Traditional surgical Hemostasis |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-08-01
- Completion
- 2010-09-01
- First posted
- 2009-11-05
- Last updated
- 2012-02-22
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01008436. Inclusion in this directory is not an endorsement.